Erik Engelson - Mar 3, 2023 Form 4 Insider Report for Lucira Health, Inc. (LHDXQ)

Role: President and Chief Executive, Director
Signature: /s/ Erik Engelson
Stock symbol: LHDXQ
Transactions as of: Mar 3, 2023
Transactions value $: -$186,080
Form type: 4
Date filed: 3/13/2023, 06:30 PM
Previous filing: Sep 19, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LHDXQ	Common Stock	Options Exercise	$471K	+575K	+690.02%	$0.82^*	658K	Mar 3, 2023	Direct
transaction	LHDXQ	Common Stock	Sale	-$592K	-575K	-87.34%	$1.03^*	83.3K	Mar 3, 2023	Direct
transaction	LHDXQ	Common Stock	Sale	-$65.4K	-60K	-72.04%	$1.09^*	23.3K	Mar 3, 2023	Direct
holding	LHDXQ	Common Stock						46.4K	Mar 3, 2023	See Footnotes	F1
holding	LHDXQ	Common Stock						192K	Mar 3, 2023	See Footnotes	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LHDXQ	Common Stock	Options Exercise	$0	-575K	-100%	$0.00^*	0	Mar 3, 2023	Common Stock	575K	$0.82	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held by the Elizabeth North Engelson Trust, dated January 17, 2001, for which Mr. Engelson serves as trustee.
F2	The shares are held by Epic Pacific, LLC, of which Mr. Engelson is a Member. Mr. Engelson disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F3	The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option shall vest monthly over the four years from the vesting commencement date.